Primary |
Type 2 Diabetes Mellitus |
45.1% |
Diabetes Mellitus |
29.3% |
Hypertension |
8.5% |
Neck Pain |
4.9% |
Hypercholesterolaemia |
2.4% |
Hypertriglyceridaemia |
2.4% |
Angina Unstable |
1.2% |
Blood Glucose Fluctuation |
1.2% |
Hypotension |
1.2% |
Hypothyroidism |
1.2% |
Myocardial Infarction |
1.2% |
Prophylaxis |
1.2% |
|
Flatulence |
18.0% |
Hypoglycaemia |
6.0% |
Jaundice |
6.0% |
Weight Decreased |
6.0% |
Angioedema |
4.0% |
Hyperkalaemia |
4.0% |
Hypotension |
4.0% |
Lipase Increased |
4.0% |
Overdose |
4.0% |
Pancreatitis |
4.0% |
Pancreatitis Acute |
4.0% |
Periorbital Oedema |
4.0% |
Pruritus |
4.0% |
Rash Generalised |
4.0% |
Respiratory Disorder |
4.0% |
Tachycardia |
4.0% |
Thrombocytopenia |
4.0% |
Tremor |
4.0% |
Urticaria |
4.0% |
White Blood Cells Urine Positive |
4.0% |
|
Secondary |
Product Used For Unknown Indication |
22.9% |
Diabetes Mellitus |
21.1% |
Hypertension |
16.5% |
Neck Pain |
8.7% |
Type 2 Diabetes Mellitus |
6.4% |
Hypercholesterolaemia |
3.2% |
Bipolar Disorder |
2.8% |
Colon Cancer |
2.8% |
Agitation |
1.8% |
Dementia |
1.8% |
Back Pain |
1.4% |
Fungal Infection |
1.4% |
Fungal Skin Infection |
1.4% |
Hypothyroidism |
1.4% |
Parkinson's Disease |
1.4% |
Prophylaxis |
1.4% |
Arrhythmia |
0.9% |
Atrial Fibrillation |
0.9% |
Diabetes Mellitus Inadequate Control |
0.9% |
Hyperlipidaemia |
0.9% |
|
Pemphigoid |
8.8% |
Proteinuria |
8.8% |
Pruritus |
8.8% |
Pulmonary Arterial Hypertension |
8.8% |
Dyspnoea Exertional |
5.9% |
Leukocytoclastic Vasculitis |
5.9% |
Presyncope |
5.9% |
Renal Failure |
5.9% |
Urinary Incontinence |
5.9% |
Vomiting |
5.9% |
Acidosis |
2.9% |
Acute Generalised Exanthematous Pustulosis |
2.9% |
Atrioventricular Block Complete |
2.9% |
Death |
2.9% |
Dyspnoea |
2.9% |
Facial Paresis |
2.9% |
Glomerulonephritis Acute |
2.9% |
Hyperkalaemia |
2.9% |
Hypothermia |
2.9% |
Left Ventricular Hypertrophy |
2.9% |
|
Concomitant |
Diabetes Mellitus |
17.8% |
Type 2 Diabetes Mellitus |
14.8% |
Product Used For Unknown Indication |
13.7% |
Hypertension |
10.4% |
Chronic Hepatitis C |
4.4% |
Prophylaxis |
4.1% |
Osteoporosis |
3.7% |
Hepatitis C |
3.3% |
Myocardial Ischaemia |
3.3% |
Psoriasis |
3.0% |
Infusion |
2.6% |
Thrombosis Prophylaxis |
2.6% |
Atrial Fibrillation |
2.2% |
Dyslipidaemia |
2.2% |
Hyperuricaemia |
2.2% |
Organising Pneumonia |
2.2% |
Rheumatoid Arthritis |
2.2% |
Pain |
1.9% |
Parkinson's Disease |
1.9% |
Coronary Artery Disease |
1.5% |
|
Renal Failure Acute |
10.4% |
Vomiting |
10.4% |
Psoriasis |
8.3% |
Hyperglycaemia |
6.3% |
Skin Disorder |
6.3% |
Skin Lesion |
6.3% |
Urticaria |
6.3% |
Deep Vein Thrombosis |
4.2% |
Lung Neoplasm Malignant |
4.2% |
Oedema Peripheral |
4.2% |
Pancytopenia |
4.2% |
Pemphigoid |
4.2% |
Rash |
4.2% |
Renal Tubular Necrosis |
4.2% |
Rhabdomyolysis |
4.2% |
Septic Shock |
4.2% |
Anaemia Haemolytic Autoimmune |
2.1% |
Cardiac Failure |
2.1% |
Chest Pain |
2.1% |
Dizziness |
2.1% |
|
Interacting |
Diabetes Mellitus |
33.3% |
Hypertension |
33.3% |
Pain |
33.3% |
|
Renal Tubular Necrosis |
50.0% |
Weight Decreased |
50.0% |
|